Has Theodore Maglione, MD received payments from drug or device companies?

Yes. Drug and device makers reported $19,424 in general payments to Theodore Maglione, MD across 144 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Theodore Maglione, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Theodore Maglione, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Theodore Maglione, MD

Clinical Cardiac Electrophysiology · New Brunswick, NJNPI 1932444940

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (43.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Biosense Webster, Inc. at 28.6% of the total. Reporting peaked in 2024 at $8,916 and has fallen 64.5% since, to $3,169 in 2025.

$19,424in general payments, 2019–2025

Across 144 payments — averaging $134.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biosense Webster, Inc.$6K
Medtronic$4K
Abbott$4K
Boston Scientific$3K
ZOLL Respicardia, Inc.$919
Medical Device Business Services, Inc.$543
plus $777 from 9 others

$475in research payments, 2019–2025

Across 1 payment — averaging $475.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$475

What the payments were for

Consulting fees$5,98931%
Travel & lodging$8,51644%
Food & beverage$4,91925%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biosense Webster, Inc.	38	$5,560
Medtronic(2 entities)	44	$4,320
Abbott	10	$4,001
Boston Scientific	25	$3,304
ZOLL Respicardia, Inc.	3	$919
Medical Device Business Services, Inc.	2	$543
Philips North America LLC	4	$359
Irhythm Technologies, Inc.	4	$154
E.r. Squibb & Sons, L.L.C.	6	$97
Cardiva Medical, Inc.	3	$57
Angiodynamics, Inc.	1	$31
Baxter Healthcare	1	$25
AstraZeneca	1	$20
Lantheus Medical Imaging, Inc.	1	$19
Boehringer Ingelheim	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,424 in reported general payments places this provider in the 55th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.

See all clinical cardiac electrophysiology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$146,757

Medicare patients

2,830

Services billed

5,213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	157	$168,061
MultaqDronedarone Hcl	61	$73,079
XareltoRivaroxaban	23	$24,320
Flecainide Acetate	34	$2,165
Metoprolol Succinate	61	$1,629
Amiodarone Hcl	19	$655
Diltiazem 24hr Er (Cd)Diltiazem Hcl	11	$417
Pravastatin Sodium	12	$369
Lisinopril	15	$166
Colchicine	13	$69

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in New Brunswick

Ahmad HalawaNew Brunswick$20K
Benjamin D SouzaCherry Hill$741K
Suneet MittalParamus$722K
George MarkHaddon Heights$312K
Raffaele CorbisieroBrowns Mills$135K
Emad AzizNewark$112K
Marc RoelkeWest Orange$110K
Arjun TheerthamParlin$102K
Michael LinkGalloway$96K
Grant SimonsEnglewood$93K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →